Subsequently, a nomogram was constructed using age, clinical stage, histologic grade, tumor invasion, histological type and S100A2 levels as indicators to predict 1-, 3-, and 5-year OS in patients with endometrial carcinoma (Fig. 6a). This evidence concerns the gene S100A2 and neoplasm.